Article Information
History
- November 13, 2025.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Daniel Schulz1,2,†,
- Marie Morfouace3,4,†,
- Bruno Palau Fernandez1,2,
- Marcin Możejko5,
- Sophie Déglise1,2,
- Michelle Daniel1,2,
- Nils Eling1,2,
- Henoch S Hong6,
- Stephanie Tissot7,8,9,
- Sylvie Rusakiewicz7,8,9,
- Timo Trefzer10,
- Jane Merlevede11,12,13,
- Flavia Marzetta14,
- Natalie de Souza1,2,
- Damian Wójtowicz5,
- Ewa Szczurek5,15,
- Benjamin Besse3 and
- Bernd Bodenmiller1,2,*
- 1Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland
- 2Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland
- 3Institut Gustave Roussy, Villejuif, France
- 4EORTC HQ, Avenue E. Mounier 83/11, 1200, Brussels, Belgium
- 5Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, Poland
- 6the healthcare organization of Merck KGaA, Darmstadt, Germany
- 7Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
- 8Ludwig Institute for Cancer Research, Lausanne branch, Lausanne, Switzerland
- 9Immune Landscape Laboratory, Centre Thérapies Expérimentales (CTE), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
- 10Research & Early Development Oncology, Bayer AG, Berlin, Germany
- 11Institut Curie, PSL University, Paris, France
- 12Institut National de la Santé et de la Recherche Médicale (INSERM), U1331, Paris, France
- 13Mines Paris, PSL University, CBIO - Centre for Computational Biology, Paris, France
- 14Vital-IT group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
- 15Institute of AI for Health, Helmholtz Zentrum München, Germany
- ↵*Correspondence: bernd.bodenmiller{at}uzh.ch
Posted November 13, 2025.
Comprehensive characterization of early-stage Non-Small Cell Lung cancers with multi-modal data integration
